Kewaunee Scientific (KEQU) Competitors

Standard BioTools (NASDAQ:LAB) and Kewaunee Scientific (NASDAQ:KEQU) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

Which has stronger earnings & valuation, LAB or KEQU?

Kewaunee Scientific has higher revenue and earnings than Standard BioTools. Standard BioTools is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Standard BioTools	$169.69M	2.41	-$74.66M	-$0.35	-3.07
Kewaunee Scientific	$220.03M	0.48	$18.75M	$5.91	6.31

Does the MarketBeat Community prefer LAB or KEQU?

Kewaunee Scientific received 137 more outperform votes than Standard BioTools when rated by MarketBeat users. However, 83.33% of users gave Standard BioTools an outperform vote while only 67.62% of users gave Kewaunee Scientific an outperform vote.

Company	Underperform	Outperform
Standard BioTools	Outperform Votes 5 83.33%	Underperform Votes 1 16.67%
Kewaunee Scientific	Outperform Votes 142 67.62%	Underperform Votes 68 32.38%

Which has more risk and volatility, LAB or KEQU?

Standard BioTools has a beta of 1.5, meaning that its share price is 50% more volatile than the S&P 500. Comparatively, Kewaunee Scientific has a beta of 0.56, meaning that its share price is 44% less volatile than the S&P 500.

Do analysts prefer LAB or KEQU?

Standard BioTools presently has a consensus price target of $2.50, suggesting a potential upside of 132.56%. Given Standard BioTools' stronger consensus rating and higher possible upside, equities research analysts plainly believe Standard BioTools is more favorable than Kewaunee Scientific.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Standard BioTools	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Kewaunee Scientific	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is LAB or KEQU more profitable?

Kewaunee Scientific has a net margin of 9.39% compared to Standard BioTools' net margin of -79.92%. Kewaunee Scientific's return on equity of 25.83% beat Standard BioTools' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Standard BioTools	-79.92%	-27.05%	-15.52%
Kewaunee Scientific	9.39%	25.83%	10.75%

Does the media refer more to LAB or KEQU?

In the previous week, Standard BioTools and Standard BioTools both had 2 articles in the media. Standard BioTools' average media sentiment score of 1.85 beat Kewaunee Scientific's score of 0.94 indicating that Standard BioTools is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Standard BioTools	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Kewaunee Scientific	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do institutionals & insiders believe in LAB or KEQU?

53.7% of Standard BioTools shares are held by institutional investors. Comparatively, 32.7% of Kewaunee Scientific shares are held by institutional investors. 23.2% of Standard BioTools shares are held by company insiders. Comparatively, 14.2% of Kewaunee Scientific shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Standard BioTools beats Kewaunee Scientific on 9 of the 17 factors compared between the two stocks.